PACLX
Price
$34.03
Change
-$4.12 (-10.80%)
Updated
Dec 18 closing price
VLAAX
Price
$40.89
Change
-$4.98 (-10.86%)
Updated
Dec 18 closing price
Ad is loading...

PACLX vs VLAAX

Header iconPACLX vs VLAAX Comparison
Open Charts PACLX vs VLAAXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$34.03
Change-$4.12 (-10.80%)
VolumeN/A
CapitalizationN/A
Value Line Asset Allocation Investor
Price$40.89
Change-$4.98 (-10.86%)
VolumeN/A
CapitalizationN/A
PACLX vs VLAAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PACLX vs. VLAAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and VLAAX is a Hold.

FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 66.1B vs. VLAAX (943M). PACLX pays higher dividends than VLAAX: PACLX (1.77) vs VLAAX (0.95). PACLX was incepted earlier than VLAAX: PACLX (20 years) vs VLAAX (31 years). PACLX is a more actively managed with annual turnover of: 65.10 vs. VLAAX (29.00). VLAAX has a lower initial minimum investment than PACLX: VLAAX (1000) vs PACLX (2500). VLAAX (13.60) and PACLX (13.32) have marching annual gain over last year. PACLX return over 5 years is better than : 29.42 vs. VLAAX (22.05).
PACLXVLAAXPACLX / VLAAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years31 years-
Gain YTD14.25612.647113%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets66.1B943M7,010%
Annual Yield % from dividends1.770.95187%
Returns for 1 year13.3213.6098%
Returns for 3 years9.683.15307%
Returns for 5 years29.4222.05133%
Returns for 10 years62.5668.2992%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI13.010.11
+0.85%
Greenwich LifeSciences
TXT80.07-1.27
-1.56%
Textron
FBP19.45-0.61
-3.04%
First BanCorp
IMNM12.02-0.42
-3.38%
Immunome
CTHR1.52-0.14
-8.43%
Charles & Colvard Ltd.